E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedReviewed
Standard · 3 min
Systemic Hyperalgesia in Females with Gulf War Illness, Chronic Fatigue Syndrome and Fibromyalgia.
Surian, Amber A, Baraniuk, James N · Scientific reports · 2020 · DOI
Quick Summary
This study measured how sensitive to pain women with ME/CFS, Gulf War Illness, and fibromyalgia are compared to healthy controls. Researchers used a tool called a dolorimeter to apply pressure to 18 specific body points and measured how much pressure it took before women felt pain. Women with these illnesses felt pain at much lower pressure levels than healthy women, showing they have widespread increased pain sensitivity.
Why It Matters
This study provides objective physical evidence of widespread pain sensitivity in ME/CFS and related illnesses, which could help establish dolorimetry as a measurable diagnostic tool rather than relying solely on patient-reported symptoms. Understanding that ME/CFS patients have variable levels of pain sensitivity may lead to better diagnostic criteria and inform development of targeted treatments for different subgroups.
Observed Findings
Women with GWI had the lowest pain pressure threshold (2.9 kg), followed by CFS/FM overlap (3.1 kg), FM alone (3.9 kg), CFS alone (5.8 kg), and healthy controls (7.2 kg).
A pressure threshold of 4.0 kg effectively distinguished GWI and CFS/FM from controls with 80-83% sensitivity and 85% specificity.
Dolorimetry measurements correlated with self-reported symptoms in GWI but not in CFS or FM groups.
Pain, fatigue, quality of life, and symptom severity were equivalent across GWI, CFS/FM, and CFS groups despite different pain thresholds.
Inferred Conclusions
Women with GWI, CFS, and FM all demonstrate systemic hyperalgesia compared to sedentary controls, suggesting a shared pathophysiological feature across these conditions.
Physical tenderness measured by dolorimetry could serve as an objective diagnostic criterion to complement symptom-based criteria, particularly for GWI.
The different relationships between dolorimetry and symptoms across diagnostic groups suggest that these conditions may involve distinct neuropathological mechanisms despite clinical overlap.
Remaining Questions
What biological mechanisms underlie systemic hyperalgesia in these conditions, and are they the same across GWI, CFS, and FM?
Why does dolorimetry correlate with symptoms in GWI but not in CFS or FM, and what does this reveal about differences in pain processing?
What This Study Does Not Prove
This study does not establish causation—it only demonstrates that pain sensitivity differs between groups at one point in time. The cross-sectional design cannot determine whether hyperalgesia develops before or after illness onset, nor can it explain the underlying biological mechanisms causing heightened pain sensitivity. Additionally, the lack of correlation between dolorimetry and symptoms in CFS and FM suggests that pain threshold measurements alone may not capture the full pain experience in these conditions.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
Could objective pain threshold measurements improve diagnostic accuracy and help identify clinical subtypes within CFS for more targeted treatment approaches?
Do pain sensitivity levels change over time, or remain stable once illness is established?